Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02137551 · ClinicalTrials.gov registry record · NA

ABM for ACO Beneficiaries

A NA study, sponsored by American Pharmacists Association Foundation.

Completed
Registry status
NA
Development phase
595
Enrollment target

NCT02137551 is a NA study that has completed, run by American Pharmacists Association Foundation. The registered enrollment target is 595 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02137551, a NA study, has completed, sponsored by American Pharmacists Association Foundation.

COMPLETED
Registry status
NA
Development phase
595 participants
Enrollment target

Study Summary

The primary objective of the study is to evaluate how engaging ACO beneficiaries in the appointment based model for one year impacts medication adherence and healthcare costs compared to usual care.

Interventions

  • OTHER ABM

Trial Details

FieldValue
Enrollment Target 595 participants
Start Date 2014-08
Est. Completion 2016-02
Phase NA

What the Registry Record Tells You About NCT02137551

The ClinicalTrials.gov registry entry for NCT02137551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 595 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Pharmacists Association Foundation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ABM is the first listed.

NCT02137551 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02137551 about?

NCT02137551 is a clinical study titled "ABM for ACO Beneficiaries". The primary objective of the study is to evaluate how engaging ACO beneficiaries in the appointment based model for one year impacts medication adherence and healthcare costs compared to usual care.

What is the current status of trial NCT02137551?

This trial is currently completed. It is a NA study. The enrollment target is 595 participants. The study started on 2014-08. Estimated completion is 2016-02.

What interventions are being tested in trial NCT02137551?

The interventions under investigation include: ABM (OTHER).

Who is sponsoring clinical trial NCT02137551?

This trial is sponsored by American Pharmacists Association Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.